Author

Rayyan Syed Kamal

Observed names: Kamal R, Kamal, Rayyan, Kamal, Rayyan Syed, R Kamal, R. Kamal

Institutions: Western University, Lawson Health Research Institute, London Health Sciences Centre

Observed institutions: Western University, Lawson Health Research Institute, London Health Sciences Centre, National JALMA Institute for Leprosy & Other Mycobacterial Diseases

ORCID: 0009-0001-0952-1449

Observed ORCID: 0009-0001-0952-1449

OpenAlex ID: A5103028529

Changing profile of disease in leprosy patients diagnosed in a tertiary care centre during years 1995-2000.

2008 · M Arora, K Katoch, et al. · PubMed · 25

Addition of Mycobacterium indicus pranii vaccine as an immunotherapeutic to standard chemotherapy in borderline leprosy: a double-blind study to assess clinical improvement (preliminary report)

2016 · R. Kamal, V. Pathak, et al. · British Journal of Dermatology · 22

Clinical and histopathological evaluation of the effect of addition of immunotherapy with Mw vaccine to standard chemotherapy in borderline leprosy.

2012 · R Kamal, M Natrajan, et al. · PubMed · 15

Evaluation of the diagnostic value of immunocytochemistry and in situ hybridization in the pediatric leprosy.

2013 · R Kamal, M Natrajan, et al. · PubMed · 5

Importance of Incorporating the Perspectives of People with Cancer into Oncology Education: A Scoping Review

2023 · Hanna Dutt, Arleigh Dean, et al. · Journal of Medical Education and Curricular Development · 4

Hypoglycemia as first presentation of presumed immune checkpoint inhibitor‐induced type 1 diabetes

2023 · Rayyan Syed Kamal, Arleigh Dean, et al. · Clinical Case Reports · 3

Diagnostic Role of Anti PGL-1 Antibody, Antigen 85-C and IP-10 (Interferon Gamma Inducible Protein) in Pediatric Leprosy

2018 · Dayal R R, Kamal R, et al. · International Journal of Contemporary Medical Research [IJCMR]

Works count: 11

Citation count: 74

H-index: 4

I10-index: 3